Status:
UNKNOWN
Performance of Two Intraocular Lenses With Extended Depth of Vision
Lead Sponsor:
Vienna Institute for Research in Ocular Surgery
Conditions:
Cataract Senile
Eligibility:
All Genders
21-105 years
Phase:
NA
Brief Summary
Comparison of the capsular bag performance of two extended depth of vision (EDOF) intraocular lenses (IOLs), the Rayone EMV and the Alcon Acrysof IQ Vivity, in a mini-monovision setting
Detailed Description
Spectacle independence is a rising aim in modern cataract surgery. Although bilateral monofocal IOL implantation, aiming for emmetropia leads to high levels of patient satisfaction for distance vision...
Eligibility Criteria
Inclusion
- age-related bilateral cataract
- age 21 or older
- visual acuity \> 0.05
- axial length: 22.0 - 26.0 mm
- normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
- written informed consent prior to surgery
Exclusion
- active ocular disease (e.g. chronic severe uveitis, proliferative diabetic retinopathy, chronic glaucoma not responsive to medication)
- relevant othe rophthalmic diseases such as pseudoexfoliation syndrome (PEX), intraoperative floppy iris syndrome (IFIS)
- corneal decompensation or corneal endothelial cell insufficiency
- previous ocular surgery or trauma
- persons who are pregnant or nursing (pregnancy test will be taken in women of reproductive age)
- corneal astigmatism \> 1 dpt.
- retinopathies
Key Trial Info
Start Date :
January 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 3 2024
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT05194150
Start Date
January 3 2022
End Date
January 3 2024
Last Update
January 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
Vienna, Austria, 1140